G. J. Ossenkoppele
- Hematology top 5%
- Genetics top 5%
- Rheumatology top 10%
- Public Health, Environmental and Occupational Health
- Oncology
- Co-authors
- Andreas HochhausNeil J. GallagherMichele BaccaraniFrancis J. GilesJörge E. CortesHagop M. KantarjianEdo VellengaHendrik J.M. de Jonge
- Topics
- Chronic Myeloid Leukemia Treatments (16 papers)Chronic Lymphocytic Leukemia Research (13 papers)Eosinophilic Disorders and Syndromes (8 papers)
- Cited by
- HematologyGeneticsRheumatology
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
G. J. Ossenkoppele
17 papers receiving 270 citations
Peers
Comparison fields: 5 of 29
- Hematology 263
- Genetics 206
- Rheumatology 134
- Public Health, Environmental and Occupational Health 47
- Oncology 27
Countries citing papers authored by G. J. Ossenkoppele
This map shows the geographic impact of G. J. Ossenkoppele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. J. Ossenkoppele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. J. Ossenkoppele more than expected).
Fields of papers citing papers by G. J. Ossenkoppele
This network shows the impact of papers produced by G. J. Ossenkoppele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. J. Ossenkoppele. The network helps show where G. J. Ossenkoppele may publish in the future.
Co-authorship network of co-authors of G. J. Ossenkoppele
This figure shows the co-authorship network connecting the top 25 collaborators of G. J. Ossenkoppele. A scholar is included among the top collaborators of G. J. Ossenkoppele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. J. Ossenkoppele. G. J. Ossenkoppele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 63 | |
| 3 | 59 | |
| 4 | Delaying the initiation of dasatinib after imatinib failure has a negative impact on outcome for patients with chronic-phase chronic myeloid leukemia (CP-CML): results from a European observational study (FORTE; CA180-211) | 1 |
| 5 | A european observational study of dasatinib in the management of imatinib-resistant and -intolerant patients with chronic myeloid leukemia: forte study (ca180-211) | 1 |
| 6 | 24 | |
| 7 | 15 | |
| 8 | 6 | |
| 9 | 9 | |
| 10 | 18 | |
| 11 | 13 | |
| 12 | 12 | |
| 13 | 4 | |
| 14 | 5 | |
| 15 | [Drug treatment of chronic myeloid leukemia: a cost effectiveness analysis of first- and second-line treatment ]. | 2 |
| 16 | [STI571: a new dimension in the treatment of chronic myeloid leukemia]. | 1 |
| 17 | 9 |
About G. J. Ossenkoppele
G. J. Ossenkoppele is a scholar working on Hematology, Genetics and Rheumatology, having authored 17 papers that have together received 279 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (16 papers), Chronic Lymphocytic Leukemia Research (13 papers) and Eosinophilic Disorders and Syndromes (8 papers). The work is most often cited by research in Hematology (263 citations), Genetics (206 citations) and Rheumatology (134 citations). G. J. Ossenkoppele has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Andreas Hochhaus, Neil J. Gallagher, Michele Baccarani, Francis J. Giles, Jörge E. Cortes, Hagop M. Kantarjian, Edo Vellenga, Hendrik J.M. de Jonge, Jan Jacob Schuringa and Eveline S.J.M. de Bont. Their work appears in journals such as Journal of Clinical Oncology, Leukemia and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.